Press releaseBusiness Wire
Organigram Global
OGI · TORONTO
$0.9262−$0.0104 (−1.11%)TodayMarket closed ·
Prev close $0.9366
Latest news
- Press releaseBusiness Wire
Organigram Global to Premiere The 2026 OG Investor Session Today at 4:00 p.m. ET on X
- Press releaseBusiness Wire
Organigram Global to Host 2026 OG Investor Session
- Press releaseBusiness Wire
Organigram Global Accelerates Integration of Sanity Group Under Unified Global Operating Structure
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- Press releaseBusiness Wire
Organigram Reports Record Third Quarter Fiscal 2026 Results
- Press releaseBusiness Wire
Organigram to Report Third Quarter Fiscal 2026 Results on August 11, 2026
- News
Organigram Maintains Cannabis Market Lead Ahead Of Q3 Results
- Press releaseBusiness Wire
Organigram Provides Business Update Highlighting Initial Sanity Performance and Canadian Market Share
- Press releaseGlobe Newswire
Europe's Cannabis Boom Is Accelerating as Billions Flow into Licensed Markets
- News
Transcript: OrganiGram Holdings Q2 2026 Earnings Conference Call
- NewsVandana Singh
Organigram Says Vape Weakness Pressures Margins
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- News
OrganiGram Holdings Q2 EPS $(0.01), Inline, Sales $43.597M Miss $52.060M Estimate
- News
Earnings Scheduled For May 12, 2026
- Press releaseBusiness Wire
Organigram Reports Second Quarter Fiscal 2026 Results
- Press releaseBusiness Wire
Organigram to Report Second Quarter Fiscal 2026 Results on May 12th, 2026
- Press releaseGlobe Newswire
Multibillion-Dollar Edibles Market Gains Rising Momentum as Legalization Expands
- Press releaseBusiness Wire
Organigram Closes Previously Announced Acquisition of Sanity Group, Private Placement Financing with BAT and ATB Senior Secured Credit Facilities
- Press releaseBusiness Wire
Organigram Announces Shareholder Approval of Acquisition of Sanity Group GmbH and Results of its Annual General and Special Meeting
- Press releaseBusiness Wire
Organigram Announces Independent Proxy Advisory Firm ISS Recommends Organigram Shareholders Vote FOR the Acquisition of Sanity Group GmbH
- Press releaseBusiness Wire
Organigram Announces Mailing of Management Information Circular in Connection with Annual General and Special Meeting
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Press releaseBusiness Wire
Organigram Global Expands FAST™ Innovation Platform with SHRED Shotz, Leveraging SHRED Brand Equity
- Press releaseBusiness Wire
Organigram Further Expands Global Portfolio with Launch of Edison and BOXHOT Medical Vapes and Pastilles in Australia
- Press releaseBusiness Wire
Organigram Announces C$65.2 Million BAT Private Placement Investment in Connection with the Acquisition of Sanity Group
- Press releaseBusiness Wire
Organigram Announces Proposed Acquisition of Sanity Group, a Leading German Cannabis Company
- Press releaseBusiness Wire
Organigram Reports First Quarter Fiscal 2026 Results
- News
Earnings Preview For OrganiGram Holdings
- Press releaseBusiness Wire
Organigram to Report First Quarter Fiscal 2026 Results on February 10, 2026
- Press releaseBusiness Wire
Organigram Extends Innovation Investment with Phylos
- NewsVandana Singh
White House Considers Cannabis Reclassification, Stops Short Of Legalization: Stocks To Watch
- Press releaseBusiness Wire
Organigram Reports Record Fourth Quarter and Fiscal 2025 Results
- NewsNamrata Sen
Tilray, Canopy And Other Weed Stocks Are Rallying In Friday Pre-Market— What's Going On?
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.